TORRENT PHARMACEUTICALS LTD. - Submission Of Quarterly Statement Of Investor Complaints Under Regulation 13(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

06 Oct 2017

Submission of Quarterly statement of Investor Complaints under Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Source: BSE India

View all announcements for TORRENT PHARMACEUTICALS LTD.

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist